231 related articles for article (PubMed ID: 16586069)
21. Diabetes, kidney disease and anaemia: time to tackle a troublesome triad?
Al-Khoury S; Afzali B; Shah N; Thomas S; Gusbeth-Tatomir P; Goldsmith D; Covic A
Int J Clin Pract; 2007 Feb; 61(2):281-9. PubMed ID: 17263715
[TBL] [Abstract][Full Text] [Related]
22. Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality?
Abaterusso C; Pertica N; Lupo A; Ortalda V; Gambaro G
Diabetes Obes Metab; 2008 Sep; 10(10):843-9. PubMed ID: 18093210
[TBL] [Abstract][Full Text] [Related]
23. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
[TBL] [Abstract][Full Text] [Related]
24. 'Microalbuminuric anaemia'--the relationship between haemoglobin levels and albuminuria in diabetes.
Adetunji OR; Mani H; Olujohungbe A; Abraham KA; Gill GV
Diabetes Res Clin Pract; 2009 Aug; 85(2):179-82. PubMed ID: 19481284
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and nature of anaemia in a prospective, population-based sample of people with diabetes: Teesside anaemia in diabetes (TAD) study.
Jones SC; Smith D; Nag S; Bilous MT; Winship S; Wood A; Bilous RW
Diabet Med; 2010 Jun; 27(6):655-9. PubMed ID: 20546283
[TBL] [Abstract][Full Text] [Related]
26. Impact of diabetes on haemoglobin levels in renal disease.
Ravanan R; Spiro JR; Mathieson PW; Smith RM
Diabetologia; 2007 Jan; 50(1):26-31. PubMed ID: 17131141
[TBL] [Abstract][Full Text] [Related]
27. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
Gerstein HC
Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357
[TBL] [Abstract][Full Text] [Related]
28. [Early anemia in diabetic nephropathy].
Nagy J; Kiss I; Wittmann I
Orv Hetil; 2005 Feb; 146(9):397-401. PubMed ID: 15830606
[TBL] [Abstract][Full Text] [Related]
29. Anaemia as an early predictor for diabetic renal disease? A review of the literature.
Balshaw-Greer A; Davies J; Casey J
EDTNA ERCA J; 2005; 31(3):140-2. PubMed ID: 16363414
[TBL] [Abstract][Full Text] [Related]
30. Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy.
Demetri GD
Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):31-7. PubMed ID: 11308272
[TBL] [Abstract][Full Text] [Related]
31. Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.
Mix TC; Brenner RM; Cooper ME; de Zeeuw D; Ivanovich P; Levey AS; McGill JB; McMurray JJ; Parfrey PS; Parving HH; Pereira BJ; Remuzzi G; Singh AK; Solomon SD; Stehman-Breen C; Toto RD; Pfeffer MA
Am Heart J; 2005 Mar; 149(3):408-13. PubMed ID: 15864229
[TBL] [Abstract][Full Text] [Related]
32. Diabetes mellitus with normal renal function is associated with anaemia.
Grossman C; Dovrish Z; Koren-Morag N; Bornstein G; Leibowitz A
Diabetes Metab Res Rev; 2014 May; 30(4):291-6. PubMed ID: 24170527
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease.
Bello NA; Lewis EF; Desai AS; Anand IS; Krum H; McMurray JJ; Olson K; Solomon SD; Swedberg K; van Veldhuisen DJ; Young JB; Pfeffer MA
Eur J Heart Fail; 2015 Nov; 17(11):1201-7. PubMed ID: 26423928
[TBL] [Abstract][Full Text] [Related]
34. Anaemia is common and predicts mortality in diabetic nephropathy.
Joss N; Patel R; Paterson K; Simpson K; Perry C; Stirling C
QJM; 2007 Oct; 100(10):641-7. PubMed ID: 17921197
[TBL] [Abstract][Full Text] [Related]
35. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
Targher G; Bertolini L; Zenari L; Lippi G; Pichiri I; Zoppini G; Muggeo M; Arcaro G
Diabet Med; 2008 Jan; 25(1):45-50. PubMed ID: 18199131
[TBL] [Abstract][Full Text] [Related]
36. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.
Skali H; Parving HH; Parfrey PS; Burdmann EA; Lewis EF; Ivanovich P; Keithi-Reddy SR; McGill JB; McMurray JJ; Singh AK; Solomon SD; Uno H; Pfeffer MA;
Circulation; 2011 Dec; 124(25):2903-8. PubMed ID: 22104547
[TBL] [Abstract][Full Text] [Related]
37. Vascular complications in diabetic pregnancy.
Kaaja R
Thromb Res; 2009; 123 Suppl 2():S1-3. PubMed ID: 19217462
[TBL] [Abstract][Full Text] [Related]
38. [Erythropoietin administration in diabetic patients].
Zukowska-Szczechowska E; Tomaszewski M; Sedkowska A; Grzeszczak W
Przegl Lek; 2003; 60(8):532-5. PubMed ID: 14974347
[TBL] [Abstract][Full Text] [Related]
39. Anaemia and type 2 diabetes: implications from a retrospectively studied primary care case series.
Chen CX; Li YC; Chan SL; Chan KH
Hong Kong Med J; 2013 Jun; 19(3):214-21. PubMed ID: 23568938
[TBL] [Abstract][Full Text] [Related]
40. Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Pfeffer MA; Burdmann EA; Chen CY; Cooper ME; de Zeeuw D; Eckardt KU; Ivanovich P; Kewalramani R; Levey AS; Lewis EF; McGill J; McMurray JJ; Parfrey P; Parving HH; Remuzzi G; Singh AK; Solomon SD; Toto R; Uno H;
Am J Kidney Dis; 2009 Jul; 54(1):59-69. PubMed ID: 19501439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
